
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Supplements and Featured Publications
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
Managed Care Issues in the Treatment of Gastroesophageal Reflux Diseaseabout 26 years ago
Maximizing Outcome of Extraesophageal Reflux Diseaseabout 26 years ago
Changes in the Hypopharynx May Suggest Supraesophageal Reflux Diseaseabout 26 years ago
Diagnosing and Managing Barrett's Esophagusabout 26 years ago
Guidelines for Managing Short-Segment Barrett's Esophagusabout 26 years ago
Ablative Therapies for Barrett's Esophagusabout 26 years ago
Selected Abstracts





